NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)

RecruitingN/A

Sponsor: University Hospital, Basel, Switzerland

Conditions: Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive

Interventions: All participants will be asked to provide data and samples for collection and analysis.

Countries: Switzerland

This prospective cohort study is part of the Clinnova programme and aims to (i) identify clinical imaging and omics characteristics associated with early Multiple Sclerosis (MS) and with transitioning phases to progressive MS, as well as (ii) to investigate digital biomarkers allowing the continuous clinical monitoring of those patients.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Age ≥18
* Participants are willing and able to comply with the protocol, including undergoing data and samples collection as well as study visits and examinations.
* Signed informed consent form
* In possession of a Healios+Me app compatible smartphone (iOS/Android)
* Corrected close visual acuity of ≥0.5
* Hand motor skills sufficient for using a smartphone
* Ability to follow the study procedures
* Diagnosed with MS according to the revised McDonald criteria 2017, all clinical forms inclusive (clinically isolated syndrome, RRMS, SPMS, PPMS) AND early disease stages (\< 3 years) OR transitioning phase to progressive disease as evaluated based on Expanded Disability Status Scale (EDSS).
* Enrolled in the SMSC at University Hospital Basel

There are no specific exclusion criteria.

Locations (1)

Basel, Switzerland